Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Wingerchuk

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
International MS Journal|April 26, 2006
Neuromyelitis opticaD M Wingerchuk
Current Opinion in Neurology|September 28, 1999
The natural history of multiple sclerosis: implications for trial designD M Wingerchuk, B G Weinshenker
Current Topics in Microbiology and Immunology|January 29, 2008
Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody markerB G Weinshenker, D M Wingerchuk
Neuroimaging Clinics of North America|May 22, 2001
Multiple sclerosis: epidemiology, genetics, classification, natural history, and clinical outcome measuresD M Wingerchuk, B G Weinshenker
The Cochrane Database of Systematic Reviews|November 1, 2001
Early versus late antiepileptic drug withdrawal for people with epilepsy in remissionJ I Sirven, M Sperling, D M Wingerchuk
Neurology|November 18, 1998
Paraneoplastic encephalomyelitis and seminoma: importance of testicular ultrasonographyD M Wingerchuk, J H Noseworthy, D W Kimmel
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 20, 2001
Multiple sclerosis: current pathophysiological conceptsD M Wingerchuk, C F Lucchinetti, J H Noseworthy
Neurology|December 31, 1997
Multifocal brain MRI artifacts secondary to embolic metal fragmentsD M Wingerchuk, K N Krecke, J R Fulgham
Mayo Clinic Proceedings|December 31, 1997
Clinical outcome measures and rating scales in multiple sclerosis trialsD M Wingerchuk, J H Noseworthy, B G Weinshenker
Cerebrovascular Diseases (Basel, Switzerland)|July 1, 1998
Cerebral venous thrombosis complicated by hemorrhagic infarction: factors affecting the initiation and safety of anticoagulationD M Wingerchuk, E F Wijdicks, J R Fulgham
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
International MS Journal|April 26, 2006
Neuromyelitis opticaD M Wingerchuk
Current Opinion in Neurology|September 28, 1999
The natural history of multiple sclerosis: implications for trial designD M Wingerchuk, B G Weinshenker
Current Topics in Microbiology and Immunology|January 29, 2008
Neuromyelitis optica: clinical syndrome and the NMO-IgG autoantibody markerB G Weinshenker, D M Wingerchuk
Neuroimaging Clinics of North America|May 22, 2001
Multiple sclerosis: epidemiology, genetics, classification, natural history, and clinical outcome measuresD M Wingerchuk, B G Weinshenker
The Cochrane Database of Systematic Reviews|November 1, 2001
Early versus late antiepileptic drug withdrawal for people with epilepsy in remissionJ I Sirven, M Sperling, D M Wingerchuk
Neurology|November 18, 1998
Paraneoplastic encephalomyelitis and seminoma: importance of testicular ultrasonographyD M Wingerchuk, J H Noseworthy, D W Kimmel
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 20, 2001
Multiple sclerosis: current pathophysiological conceptsD M Wingerchuk, C F Lucchinetti, J H Noseworthy
Neurology|December 31, 1997
Multifocal brain MRI artifacts secondary to embolic metal fragmentsD M Wingerchuk, K N Krecke, J R Fulgham
Mayo Clinic Proceedings|December 31, 1997
Clinical outcome measures and rating scales in multiple sclerosis trialsD M Wingerchuk, J H Noseworthy, B G Weinshenker
Cerebrovascular Diseases (Basel, Switzerland)|July 1, 1998
Cerebral venous thrombosis complicated by hemorrhagic infarction: factors affecting the initiation and safety of anticoagulationD M Wingerchuk, E F Wijdicks, J R Fulgham
Pageof 4